Avanos Medical, Inc. (AVNS) Tops Q4 EPS by 11c

Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.60, $0.11 better than the analyst estimate of $0.49. Revenue for the quarter came in at $217 million versus the consensus estimate of $217.3 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2023 EPS of $1.60-$1.80, versus the consensus of $1.68.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform